top of page
Schneider Children’s Medical Center of Israel is the only comprehensive, tertiary care hospital of its kind in the country and in the Middle East, offering the full range of pediatric disciplines under one roof to all children from 0–18. 
Psychopharmacology in pediatric oncology patients and other critically ill children.
During the treatment and diagnosis of cancer and other life-threatening illnesses, children and teens can experience depression, anxiety, and irritability. Psychopharmacological interventions for these patients are invaluable, but there is currently a lack of basic guidelines for the safe administration of these interventions. 
The Nevzlin Family Foundation supports research exploring the relative benefits of specific psychotropic medications. Such studies will facilitate the development of specific guidelines for the use of psychiatric medication in critically ill patients, and will enable us to provide the best available psychiatric treatment for children and adolescents with cancer. 
Genomic personalized cancer medicine for children.
Children with cancer experience remission, chemotherapy has toxic effects. Most children develop serious infections during chemo, and many suffer from toxicity later in life. Some even die as a result of the chemotherapy itself. Nonetheless, it is possible to manage toxicity and cure children’s cancer, with genomic and biological research into the development of personalized medicine, as well as the adjustment of existing therapies to the genomic nature of the tumors, the child’s cancer malignancy, and the cancer’s response to the therapy. The Foundation supports the creation of a Genomic Center at the Schneider Center that will:
  • Help detect the amount of cancer cells in the body after cancer treatment
  • Adjust children’s therapy for leukemia based on personalized factors
  • Detect mutations in childhood cancer
  • Develop blood tests to monitor the growth and response to therapy of solid tumors in children
bottom of page